go-v.orgdoi

New developments in the treatment of chronic thromboembolic pulmonary hypertension

Irene Marthe Lang · Clinical Investigation · 2012

  • DOI 10.4155/cli.12.25
  • Publisher OMICS Publishing Group
  • Type article
  • Issued 2012

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Investigation · OMICS Publishing Group · article · 2012

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by pulmonary arterial obstructions that typically result from non-resolving fibrotic organized pulmonary thromboemboli, causing elevated pulmonary vascular resistance, progressive pulmonary hypertension and, eventually, right heart failure. In more than 50% of patients, particularly those with a history of venous thromboembolism, CTEPH is a ‘surgical disorder’ meaning that the treatment of choice is a pulmonary endarterectomy, which restores pulmonary hemodynamics in a great majority of patients.

However, in a recent registry, 36.4% of patients in major European expert centers were classified as non-operable, mainly due to surgically inaccessible thrombi or unacceptably high risk for surgery in general. Because of the observation of a secondary pulmonary vascular disease in some patients, pulmonary arterial hypertension (PAH)-targeted pharmacotherapies have been widely used in CTEPH patients – in up to 40% of patients in Europe – regar...

Open the resolved locator · 10.4155/cli.12.25

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 04:10 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.4155/cli.12.25
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.